These days, just about everyone is recommending a different way to lose weight. Whether it’s the latest ultra-low-fat diet, high-intensity exercise regimes like CrossFit or medications injected weekly ...

Note: The U.S. Food and Drug Administration (FDA) does not approve supplements for safety or effectiveness before being sold or marketed. Talk to a healthcare professional about whether a supplement ...

People who carry variations in two genes linked to appetite and digestion can lose more weight when taking drugs such as Wegovy and Mounjaro to treat obesity, research suggests. The findings, outlined ...

The U.S. Food and Drug Administration’s approval of Eli Lilly’s once-daily pill orforglipron as a weight loss and obesity treatment this week was the fastest approval of a new medication in decades.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. INDIANAPOLIS, INDIANA - MARCH 17: A flag flies above the headquarters campus of Eli Lilly ...

The success of GLP-1 medications has made drugs like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and orforglipron (Foundayo) seem like a magic bullet for weight loss. But using ...

The Food and Drug Administration granted a speedy approval Wednesday to Eli Lilly’s new weight-loss pill called Foundayo. The agency approved the pill for “use in combination with a reduced-calorie ...

The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive ...

Federal regulators on Wednesday approved Eli Lilly's new weight-loss pill, a second daily oral medication to treat obesity and other weight-related conditions. The Food and Drug Administration granted ...

Over 40% of people taking Xenical achieved a 5% decrease in their starting body weight. Saxenda users achieved a 5% decrease in their body weight in more than 63% of cases. Eating a balanced diet and ...

Meaghan is an editor and writer who also has experience practicing holistic medicine as an acupuncturist and herbalist. She's passionate about helping individuals live full, healthy and happy lives at ...

Maggie Linton has never been fond of injections, so when she heard that Eli Lilly was working on a GLP-1 pill, she was eager to sign up for a clinical trial and put the new medication to the test.